{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:30:10Z","timestamp":1767918610511,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101503"],"award-info":[{"award-number":["82101503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271452"],"award-info":[{"award-number":["82271452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["SQ2022YFC3500330"],"award-info":[{"award-number":["SQ2022YFC3500330"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jpsychires.2023.10.028","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T09:49:46Z","timestamp":1697449786000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of tandospirone and escitalopram as a symptomatic treatment in Multiple System Atrophy-cerebellar ataxia: An open-label, non-controlled, 4 weeks observational study"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-0798","authenticated-orcid":false,"given":"Meina","family":"Quan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2023.10.028_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.20021","article-title":"Involvement of medullary serotonergic groups in multiple system atrophy","volume":"55","author":"Benarroch","year":"2004","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.10.028_bib2","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1007\/s00415-020-09881-6","article-title":"An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention","volume":"267","author":"Chelban","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.10.028_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.27343","article-title":"Autonomic dysfunction in genetic forms of synucleinopathies","volume":"33","author":"Chelban","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2019.04.024","article-title":"A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: a pilot randomized controlled trial at a single-center in China","volume":"114","author":"Chen","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jpsychires.2022.12.023","article-title":"Augmentation therapy with tandospirone citrate in vascular depression patients with mild cognitive impairment: a prospective randomized clinical trial","volume":"159","author":"Chen","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"10128","key":"10.1016\/j.jpsychires.2023.10.028_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.10.028_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.parkreldis.2011.12.009","article-title":"Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time","volume":"18","author":"Damon-Perriere","year":"2012","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.10.028_bib8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/ana.23700","article-title":"Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19","volume":"72","author":"Duarri","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.10.028_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acn3.50987","article-title":"Cognition in multiple system atrophy: a single-center cohort study","volume":"7","author":"Eschlbock","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.10.028_bib10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/mds.27917","article-title":"Urinary retention discriminates multiple system atrophy from Parkinson's disease","volume":"34","author":"Fanciulli","year":"2019","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.10.028_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/B978-0-444-64142-7.00065-5","article-title":"Clinical neurophysiology of multiple system atrophy","volume":"161","author":"Farooq","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.10.028_bib13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"60","key":"10.1016\/j.jpsychires.2023.10.028_bib14","doi-asserted-by":"crossref","first-page":"102705","DOI":"10.18632\/oncotarget.22170","article-title":"Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.10.028_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib16","article-title":"Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study","volume":"380","author":"Jia","year":"2023","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.10.028_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","article-title":"Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy","volume":"89","author":"Koga","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.10.028_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40520-013-0068-z","article-title":"Evaluating the prevalence of dementia in hospitalized older adults and effects of comorbid dementia on patients' hospital course","volume":"25","author":"Li","year":"2013","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2022.08.129","article-title":"Disorder-specific impaired neurocognitive function in major depression and generalized anxiety disorder","volume":"318","author":"Luo","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.10.028_bib20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/mds.27894","article-title":"Multiple system atrophy: recent developments and future perspectives","volume":"34","author":"Meissner","year":"2019","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.10.028_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.28295","article-title":"Brain 5-HT1A receptor binding in multiple system atrophy: an [(18) F]-MPPF PET study","volume":"36","author":"Meyer","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnana.2020.00026","article-title":"Interactions between the serotonergic and other neurotransmitter systems in the basal ganglia: role in Parkinson's disease and adverse effects of L-DOPA","volume":"14","author":"Munoz","year":"2020","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.03.054","article-title":"Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior","volume":"180","author":"Murata","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2023.10.028_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2013.05.029","article-title":"The role of serotonin in cerebellar development","volume":"248","author":"Oostland","year":"2013","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.10.028_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jchemneu.2011.04.005","article-title":"Serotonin innervation of basal ganglia in monkeys and humans","volume":"41","author":"Parent","year":"2011","journal-title":"J. Chem. Neuroanat."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.10.028_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.28313","article-title":"Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations","volume":"36","author":"Perez-Lloret","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.10.028_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.10.028_bib28","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/mds.28569","article-title":"Fluoxetine for the symptomatic treatment of multiple system atrophy: the MSA-FLUO trial","volume":"36","author":"Rascol","year":"2021","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.10.028_bib29","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00415-017-8604-y","article-title":"Non-motor multiple system atrophy associated with sudden death: pathological observations of autonomic nuclei","volume":"264","author":"Riku","year":"2017","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.10.028_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12311-010-0199-0","article-title":"Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study","volume":"9","author":"Takei","year":"2010","journal-title":"Cerebellum"},{"issue":"11","key":"10.1016\/j.jpsychires.2023.10.028_bib31","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.20153","article-title":"Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT","volume":"19","author":"Visser","year":"2004","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.10.028_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mdc3.12289","article-title":"Urinary dysfunctions are more severe in the parkinsonian phenotype of multiple system atrophy","volume":"3","author":"Yamamoto","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.10.028_bib33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/jnnp.2004.061036","article-title":"When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study","volume":"76","author":"Yamamoto","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623004661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623004661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:39:38Z","timestamp":1758368378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395623004661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":33,"alternative-id":["S0022395623004661"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.10.028","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of tandospirone and escitalopram as a symptomatic treatment in Multiple System Atrophy-cerebellar ataxia: An open-label, non-controlled, 4 weeks observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}